286 - Division for Drug Discovery and Development - Scientific Achievement Award Lecture and Notable Abstracts Platform Presentations

Session Chair(s)

• Don Button

  Switch Therapeutics

• Alicja Urbaniak

  Presenting Author
  University of Arkansas for Medical Sciences

This session will highlight oral presentations by young scientists doing research in Drug Discovery and Development who were selected from the submitted abstracts. Additionally, the session session will feature a keynote from the 2022 Scientific Achievement in Drug Discovery and Development awardee.

Presentations:

• 1:00 PM – 1:05 PM

  Introduction
• 1:05 PM – 1:20 PM

  RXFP2 Small Molecule Agonists: Potential Therapeutics for Osteoporosis
  

  Presenting Author: Maria Esteban-Lopez – Florida International University
• 1:20 PM – 1:35 PM

  Analgesic and Antinociceptive Effects of (2R,6R)-hydroxynorketamine (HNK) in Mice
  

  Presenting Author: Jonathan Yost – Uniformed Services University of the Health Sciences
• 1:35 PM – 1:50 PM

  Receptor binding profiles and behavioral effects of psilocybin analogs
  

  Presenting Author: Grant Glatfelter – National Institute on Drug Abuse Intramural Research Program
• 1:50 PM – 1:55 PM

  Introduction of Awardee
• 1:55 PM – 2:55 PM

  Perseverance in Academic Drug Discovery: Development of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 for the Treatment of Parkinson’s Disease
  

  Speaker: Colleen Niswender – Vanderbilt University
• 2:55 PM – 3:00 PM

  Award Presentation